Evidence map›Paper›PMID 42094143›Full record

ArticlemedRxiv : the preprint server for health sciences2026

Genome-wide detection and clinical prioritization of tandem repeat outliers using long-read sequencing.

Sophia B Gibson, Nikhita Damaraju, J Gus Gustafson, Elsa V Balton, Sirisak Chanprasert, Ian A Glass, Martha Horike-Pyne, Runjun D Kumar, Kathleen A Leppig, Chris Lundberg and 12 more

Abstract readPreprint
In one paragraph

Article in medRxiv : the preprint server for health sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors.

Sophia B GibsonDepartment of Genome Sciences, University of Washington, Seattle, WA.ORCID 0000-0001-9839-9045
Nikhita DamarajuDivision of Genetic Medicine, Department of Pediatrics, University of Washington, Seattle, WA.
J Gus GustafsonDivision of Genetic Medicine, Department of Pediatrics, University of Washington, Seattle, WA.
Elsa V BaltonDivision of Medical Genetics, Department of Medicine, University of Washington, Seattle, WA.
Sirisak ChanprasertDivision of Medical Genetics, Department of Medicine, University of Washington, Seattle, WA.
Ian A GlassDivision of Genetic Medicine, Department of Pediatrics, University of Washington, Seattle, WA.
Martha Horike-PyneDivision of Medical Genetics, Department of Medicine, University of Washington, Seattle, WA.
Runjun D KumarDepartment of Laboratory Medicine and Pathology, University of Washington, Seattle, WA.
Kathleen A LeppigDivision of Medical Genetics, Department of Medicine, University of Washington, Seattle, WA.
Chris LundbergDivision of Medical Genetics, Department of Medicine, University of Washington, Seattle, WA.
Jane RanchalisDivision of Medical Genetics, Department of Medicine, University of Washington, Seattle, WA.
Elisabeth A RosenthalDivision of Medical Genetics, Department of Medicine, University of Washington, Seattle, WA.
Andrew K SolomonDivision of Rheumatology, Department of Medicine, University of Washington, Seattle, WA.
Andrew B StergachisDepartment of Genome Sciences, University of Washington, Seattle, WA.
Mark WenerDivision of Rheumatology, Department of Medicine, University of Washington, Seattle, WA.
Undiagnosed Diseases Network
Gail P JarvikDepartment of Genome Sciences, University of Washington, Seattle, WA.
Elizabeth E BlueInstitute for Public Health Genetics, University of Washington School of Public Health, Seattle, WA.
Katrina M DippleDivision of Genetic Medicine, Department of Pediatrics, University of Washington, Seattle, WA.
Harriet DashnowDepartment of Biomedical Informatics, University of Colorado Anschutz, Aurora, CO.
Lea M StaritaDepartment of Genome Sciences, University of Washington, Seattle, WA.
Danny E MillerDepartment of Genome Sciences, University of Washington, Seattle, WA.ORCID 0000-0001-6096-8601

Funding

Diagnosing the Unknown for Care and Advancing Science (DUCAS)U2CNS132415 · NINDS · HARVARD MEDICAL SCHOOL · PI Francis Sessions Cole · 2023 to 2026
$32.1M
Pacific Northwest Undiagnosed Diseases Network Clinical SiteU01NS134355 · NINDS · UNIVERSITY OF WASHINGTON · PI ELIZABETH ELOYCE BLUE, Katrina M Dipple · 2023 to 2026
$3.0M
Long-read DNA and RNA sequencing to identify disease-causing genetic variation and streamline testingDP5OD033357 · OD · UNIVERSITY OF WASHINGTON · PI MILLER, DANNY ERWIN · 2022 to 2025
$1.9M
Revealing new short tandem repeat variation in the human population across sequencing technologies: towards rare disease diagnosis and discoveryR00HG012796 · NHGRI · UNIVERSITY OF COLORADO DENVER · PI Harriet Dashnow · 2024 to 2026
$747k
NHGRI NIH HHS R00 HG012796NIH HHS DP5 OD033357NINDS NIH HHS U01 NS134355NINDS NIH HHS U2C NS132415
6 · The paper itself

Abstract

Background: Tandem repeat expansions (TREs) cause over 60 known neurological, neuromuscular, and developmental disorders. Detecting these expansions genome-wide is challenging due to their size, sequence complexity (including interruptions), and population variation. While long-read sequencing is an emerging technology that can fully resolve many TREs, no methods have been described for genome-wide identification and prioritization of candidate pathogenic TREs with this technology. Methods: Using a newly developed pipeline called TRoLR (Tandem Repeat outliers identified with Long Reads), we analyzed haplotype-resolved long-read genome assemblies from 471 ancestrally diverse individuals to define population distributions for over three million tandem repeat loci, capturing clinically relevant interruptions. Outlier expansions were identified relative to these distributions and prioritized by genomic location and comparison to known pathogenic loci. The framework was applied to 47 cases from the Undiagnosed Diseases Network. Results: Population stratification of repeat metrics was observed at 7% of loci, with highest variability among individuals of African ancestry. Outlier analysis confirmed known pathogenic Conclusions: Quantifying the longest uninterrupted repeat segment in long-read assemblies enables detection of clinically relevant repeat expansions and loss of stabilizing interruptions. This approach enhances both diagnostic confirmation and discovery of candidate pathogenic expansions, with implications for clinical interpretation and research into complex repeat-mediated disorders.

Indexed as

clinical genomicslongest pure segmentlong-read sequencingoutlier detectionpopulation referencerepeat expansion disorderstandem repeat expansion

Identifiers

PMID42094143
PMCPMC13142565

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.